Company Name or Ticker Symbol
Search for other Categories

Lescarden Inc  (LCAR)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

LCAR's Revenue Year on Year Growth by Quarter and Year

Lescarden Inc's Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
LCAR Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter May - 0.01 0.05 0.01
III Quarter February - 0.07 0.02 0.06
II Quarter November 0.04 0.01 0.17 0.01
I Quarter August 0.35 0.03 0.01 0.31
FY   0.39 0.12 0.25 0.39

Financial Statements
Lescarden Inc's second quarter 2017 Revenue $ 0.04 millions LCAR's Income Statement
Lescarden Inc's second quarter 2016 Revenue $ 0.01 millions Quarterly LCAR's Income Statement
LCAR's Growth by Division See LCAR's Growth by Segment

LCAR Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter May - -80 % 400 % -
III Quarter February - 250 % -66.67 % -53.85 %
II Quarter November 319.6 % -94.12 % 1600 % -96.3 %
I Quarter August 1066.67 % 200 % -96.77 % 1450 %
FY   - -52 % -35.9 % -

LCAR Revenue Growth Comment
Lescarden Inc reported Revenue surge of 319.6% year on year in the second quarter, to $ 0.04 millions, this is lower than Lescarden Inc's recent average Revenue surge of 340.32%.

Looking into second quarter results within Biotechnology & Drugs industry 6 other companies have achieved higher Revenue growth. While Lescarden Inc' s Revenue doubling of 319.6% ranks overall at the positon no. 83 in the second quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #7
Healthcare Sector #19
S&P 500 #83
Revenue Y/Y Growth Statistics
High Average Low
1834.94 % 340.32 % -97.5 %
(Aug 31 2013)   (Aug 31 2014)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LCAR's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LCAR's Competitors
Revenue Growth for Lescarden Inc's Suppliers
Revenue Growth for LCAR's Customers

You may also want to know
LCAR's Annual Growth Rates LCAR's Profitability Ratios LCAR's Asset Turnover Ratio LCAR's Dividend Growth
LCAR's Roe LCAR's Valuation Ratios LCAR's Financial Strength Ratios LCAR's Dividend Payout Ratio
LCAR's Roa LCAR's Inventory Turnover Ratio LCAR's Growth Rates LCAR's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Nov 30 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Nov 30 2016
Orgenesis Inc.  425.11 %$ 425.109 millions
Lescarden Inc  302.61 %$ 302.610 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
TGEN's Profile
Stock Price
TGEN's Financials
TGEN's Expectations
Business Description
Charts & Quotes
TGEN's News
TGEN's Competitors
Customers & Markets
Economic Indicators
TGEN's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com